Medtronic says its proposed, $43 billion acquisition of Covidien has cleared all anti-trust hurdles worldwide, setting the stage for shareholder votes next month.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uP5tpe
Cap comentari:
Publica un comentari a l'entrada